Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02909972
Title Safety Study of ALRN-6924 in Patients With Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Aileron Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Denver Colorado 80218 United States Details
Tampa Florida 33612 United States Details
Bronx New York 10461 United States Details
Portland Oregon 97239-3098 United States Details
Greenville South Carolina 29605 United States Details
Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field